SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11315	Companies
251418	Keywords
180508	Articles
137249	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 09/27/2024 at 15:35, 2 years 1 month ago

Communiqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO
La FDA approuve Dupixent comme premier médicament biologique pour la BPCO aux États-Unis, offrant un nouveau traitement aux patients inadéquatement contrôlés. Résultats positifs des études BOREAS et NOTUS

FDA Traitement Études BPCO Dupixent
BRIEF

published on 09/27/2024 at 13:05, 2 years 1 month ago

Dupixent Authorized in China as First Biologic Medicine for COPD Patients

China Approval COPD Dupixent Biologic Medicine
BRIEF

published on 09/27/2024 at 13:05, 2 years 1 month ago

Dupixent autorisé en Chine comme premier médicament biologique pour les patients atteints de BPCO

Chine MPoC Approbation Dupixent Médecine Biologique
PRESS RELEASE

published on 09/27/2024 at 13:00, 2 years 1 month ago

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China

China COPD Dupixent Biologic Medicine Phase 3 Studies
PRESS RELEASE

published on 09/27/2024 at 13:00, 2 years 1 month ago

Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO
Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO, réduit les exacerbations et améliore la fonction respiratoire. Approbation suite à études de phase III

Traitement Chine Approbation BPCO Dupixent
BRIEF

published on 09/21/2024 at 00:41, 2 years 1 month ago

Approbation du Sarclisa aux États-Unis pour le traitement du myélome multiple

FDA Sanofi Myélome Multiple Sarclisa Traitement De Première Ligne
BRIEF

published on 09/21/2024 at 00:41, 2 years 1 month ago

Sarclisa Approved in the United States for the Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa First Line Treatment
PRESS RELEASE

published on 09/21/2024 at 00:36, 2 years 1 month ago

Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué (...)
La FDA approuve le Sarclisa aux États-Unis en association avec un traitement conventionnel pour les patients atteints de myélome multiple nouvellement diagnostiqué, non éligibles à une transplantation. Sanofi comble un vide thérapeutique important

FDA Traitement Sanofi Myélome Multiple Sarclisa
BRIEF

published on 09/20/2024 at 13:50, 2 years 1 month ago

Le CHMP recommande l'approbation du Dupixent pour les enfants de 12 mois et plus

Médicament Dupixent Enfants CHMP Œsophagite
BRIEF

published on 09/20/2024 at 13:50, 2 years 1 month ago

CHMP recommends approval of Dupixent for children aged 12 months and older

Children Medicine Dupixent CHMP Esophagitis

Accesswire

Published on 11/11/2026 at 03:30, 2 hours 37 minutes ago

CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 5 hours 27 minutes ago

Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 6 hours 37 minutes ago

CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 7 hours 7 minutes ago

Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 7 hours 7 minutes ago

Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary

View all ACCESSWIRE

EQS Group

Published on 11/11/2026 at 03:25, 2 hours 42 minutes ago

Experts Gather in Nanjing to Explore the Cultural Heritage of the Yangtze River
Published on 11/11/2026 at 00:15, 5 hours 52 minutes ago

Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 6 hours 52 minutes ago

GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 21:24, 8 hours 43 minutes ago

EQS-Adhoc: Kapsch TrafficCom AG:
Published on 11/10/2026 at 21:18, 8 hours 49 minutes ago

ARYZTA director steps down

Les Echos

Published on 11/10/2026 at 18:00, 12 hours 7 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 12 hours 22 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 12 hours 27 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 12 hours 32 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 12 hours 36 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE